NL8902657A - Cyclosporine bevattende ophthalmische preparaten. - Google Patents

Cyclosporine bevattende ophthalmische preparaten. Download PDF

Info

Publication number
NL8902657A
NL8902657A NL8902657A NL8902657A NL8902657A NL 8902657 A NL8902657 A NL 8902657A NL 8902657 A NL8902657 A NL 8902657A NL 8902657 A NL8902657 A NL 8902657A NL 8902657 A NL8902657 A NL 8902657A
Authority
NL
Netherlands
Prior art keywords
preparation
eye
present
amount
component
Prior art date
Application number
NL8902657A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8902657A publication Critical patent/NL8902657A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NL8902657A 1988-10-26 1989-10-26 Cyclosporine bevattende ophthalmische preparaten. NL8902657A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26
US26286688 1988-10-26

Publications (1)

Publication Number Publication Date
NL8902657A true NL8902657A (nl) 1990-05-16

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8902657A NL8902657A (nl) 1988-10-26 1989-10-26 Cyclosporine bevattende ophthalmische preparaten.

Country Status (24)

Country Link
JP (1) JPH02164830A (el)
KR (1) KR900005973A (el)
AU (1) AU626928B2 (el)
BE (1) BE1003578A4 (el)
CA (1) CA2001502A1 (el)
CH (1) CH679210A5 (el)
DE (1) DE3935517A1 (el)
DK (1) DK531289A (el)
ES (1) ES2020032A6 (el)
FI (1) FI895064A0 (el)
FR (1) FR2638089A1 (el)
GB (1) GB2224205B (el)
GR (1) GR1000611B (el)
HU (1) HU203046B (el)
IL (1) IL92120A (el)
IT (1) IT1237824B (el)
LU (1) LU87613A1 (el)
MY (1) MY106271A (el)
NL (1) NL8902657A (el)
NO (1) NO894266L (el)
NZ (1) NZ231131A (el)
PT (1) PT92120B (el)
SE (1) SE8903583L (el)
ZA (1) ZA898140B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
ES2098739T3 (es) * 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
ES2402321T3 (es) * 2007-11-05 2013-04-30 Bausch & Lomb Incorporated Materiales inmiscibles en agua como vehículos para el suministro de fármacos
WO2010141648A2 (en) * 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
EP3223794A1 (en) 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
IL92120A0 (en) 1990-07-12
CH679210A5 (el) 1992-01-15
AU4371589A (en) 1990-05-03
GB2224205A (en) 1990-05-02
NZ231131A (en) 1992-06-25
DK531289D0 (da) 1989-10-25
KR900005973A (ko) 1990-05-07
NO894266L (no) 1990-04-27
FI895064A0 (fi) 1989-10-25
CA2001502A1 (en) 1990-04-26
HU895444D0 (en) 1990-01-28
IL92120A (en) 1994-02-27
BE1003578A4 (fr) 1992-04-28
MY106271A (en) 1995-04-29
IT1237824B (it) 1993-06-18
GB8924040D0 (en) 1989-12-13
DE3935517A1 (de) 1990-05-03
PT92120A (pt) 1990-04-30
NO894266D0 (no) 1989-10-26
GR1000611B (el) 1992-08-31
HUT52394A (en) 1990-07-28
SE8903583D0 (sv) 1989-10-26
DK531289A (da) 1990-04-27
GR890100690A (en) 1990-11-29
JPH02164830A (ja) 1990-06-25
IT8948485A0 (it) 1989-10-26
AU626928B2 (en) 1992-08-13
GB2224205B (en) 1992-04-15
FR2638089A1 (fr) 1990-04-27
PT92120B (pt) 1995-06-30
SE8903583L (sv) 1990-04-27
HU203046B (en) 1991-05-28
ES2020032A6 (es) 1991-07-16
LU87613A1 (fr) 1991-05-07
ZA898140B (en) 1991-06-26

Similar Documents

Publication Publication Date Title
NL8902657A (nl) Cyclosporine bevattende ophthalmische preparaten.
RU2747455C2 (ru) Циклоспорин-содержащие лекарственные формы для наружного применения и их применения
JP2006176499A (ja) 眼疾患治療剤
EP2968139B1 (en) Microemulsion topical delivery platform
JP2004346085A (ja) シクロスポリン含有眼科用組成物
CN112135603B (zh) 包含奈必洛尔的药物组合物
CN108348468A (zh) 具有生物活性亲脂性化合物的聚乙二醇化脂质纳米粒
SK284246B6 (sk) Topické prípravky s imunosupresívami
JP2020535156A (ja) 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
Diestelhorst et al. Dry drops: a new preservative-free drug delivery system
US20100174000A1 (en) Carrier in the form of oil-in-water emulsion notably intended for ophthalmic or dermocosmetic use
JP2022546980A (ja) ブドウ膜炎の治療のための眼科用組成物
McCLANAHAN et al. Ocular manifestations of chronic phenothiazine derivative administration
RU2134107C1 (ru) Препарат "гистохром" для лечения воспалительных заболеваний сетчатки и роговицы глаз
DK3229780T3 (en) Ophthalmic composition for use in the treatment of dry eye syndrome
JP2632010B2 (ja) シクロスポリン製剤
Beasley et al. Carbachol in cataract surgery
Grehn et al. Thymoxamine: a miotic for intraocular use
Alani et al. The ophthalmic rod—a new drug-delivery system II
Blanksma Concentration of timolol in aqueous humour
Schwartz APPENDIX B BIBLIOGRAPHY OF CORTICOSTEROIDS AND THE EYE
ZALTA et al. The effect of nitroglycerin ointment on the external ocular structures of rabbits
OOOSTERHUIS et al. Sulfhydryl groups of the lens proteins of the chicken in embryonic and adult

Legal Events

Date Code Title Description
BV The patent application has lapsed